1-11 of 11
Natalie Boytsov
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Belantamab Mafodotin + Bortezomib + Dexamethasone Versus 2L+ Relapsed/Refractory Multiple Myeloma Regimens: Lenalidomide-Exposed, Lenalidomide-Refractory, High-Risk Cytogenic, and 2L-Only Subpopulations: A Network Meta-Analysis

Paula Rodríguez-Otero, Joshua Richter, Ajay K. Nooka, Fredrik Schjesvold, Emily Combe, Leanne Cooper, Ollie Schofield, Indeg Sly, Nick Ballew, Jacopo Bitetti, Natalie Boytsov, Simon McNamara, Molly Purser
Journal: Blood
Blood (2024) 144 (Supplement 1): 7054.
https://doi.org/10.1182/blood-2024-198712
Published: 2024
Journal Articles

Real-World Outcomes of Medicare Fee-for-Service Beneficiaries Meeting the Eligibility Criteria for the DREAMM-7 and DREAMM-8 Clinical Trials

Simon McNamara, Natalie Boytsov, Peter Feng Wang, Maya Hanna, Anjali Franco, Benjamin Lewing, Barth Kelly, Joseph Tkacz
Journal: Blood
Blood (2023) 142 (Supplement 1): 1965.
https://doi.org/10.1182/blood-2023-181668
Published: 2023
Journal Articles

Treatment Patterns and Patient Outcomes in Relapsed/Refractory Multiple Myeloma (RRMM) Stratified By Exposure to Lenalidomide or Anti-CD38 Therapy and Double-Class Refractory Status: A Retrospective Electronic Health Record Database Study

Joshua Richter, Peter Feng Wang, Alexa Molinari, Boris Gorsh, Natalie Boytsov, Suzanne Landi, Sue Perera, Prani Paka, Teresa Palumbo, Mei Sheng Duh, Christopher Yee, Anamika Khanal, Sonia Gupta, Ajai Chari
Journal: Blood
Blood (2022) 140 (Supplement 1): 4338–4340.
https://doi.org/10.1182/blood-2022-164918
Published: 2022
Journal Articles

Belantamab Mafodotin (Belamaf) for Relapsed/Refractory Multiple Myeloma (RRMM): A Real-World Observational Study

Malin Hultcrantz, David Kleinman, Ravi Vij, Fernando Escalante, Nirali Kotowsky, Jacopo Bitetti, Christine Mackay, Natalie Boytsov, Leena Camadoo-O'Byrne, Guillaume Germain, Mei Sheng Duh, François Laliberté, Malena Mahendran, Ana Urosevic, Hans C. Lee
Journal: Blood
Blood (2022) 140 (Supplement 1): 10124–10126.
https://doi.org/10.1182/blood-2022-164929
Published: 2022
Journal Articles

The Patient Experience with Belantamab Mafodotin: Perspectives of Patients Receiving Treatment in Clinical Trials and in the Real-World

Attaya Suvannasankha, Thomas W. LeBlanc, Julia R. Correll, Chloe Carmichael, Boris Gorsh, Mona Martin, Helen Kitchen, Laurie Eliason, Madeleine Thursfield, Natalie Boytsov, Eva Brown Hajdukova, Mary Beth Lewis, Christine Mackay, Prani Paka, Alicia O'Neill, Sue Perera, Shivaranjani Naine, Alexa Molinari, Maya Hanna, David Kleinman
Journal: Blood
Blood (2022) 140 (Supplement 1): 13264–13266.
https://doi.org/10.1182/blood-2022-159637
Published: 2022
Journal Articles

Standards of Care and Treatment Patterns Among Relapsed/Refractory Multiple Myeloma Patients Initiating Second- and Third-Line Therapies

Natalie Boytsov, Boris Gorsh, Seth Anderson, Peter Feng Wang, Sue Perera, Meg Franklin
Journal: Blood
Blood (2022) 140 (Supplement 1): 12554–12555.
https://doi.org/10.1182/blood-2022-167184
Published: 2022
Journal Articles

A Retrospective Database Analysis of Treatment Pathways in US Medicare Patients with Multiple Myeloma and Prior Exposure to Daratumumab, an Immunomodulatory Agent, and a Proteasome Inhibitor

Natalie Boytsov, Anissa Cyhaniuk, Gary Leung, Feng Wang, Cosmina Hogea, Matthew Lee Smith, Pallavi Mudumby
Journal: Blood
Blood (2021) 138 (Supplement 1): 4019.
https://doi.org/10.1182/blood-2021-152230
Published: 2021
Journal Articles

Real-World Assessment of Prior Treatment Patterns in Patients Receiving Belantamab Mafodotin Using a Longitudinal Pharmacy and Medical Open Source Claims Database

Natalie Boytsov, Karen Stockl, Chi-Chang Chen, Feng Wang, Xin Wang, Yao Cao, Allison Doherty, Prani Paka
Journal: Blood
Blood (2021) 138 (Supplement 1): 4973.
https://doi.org/10.1182/blood-2021-152242
Published: 2021
Journal Articles

A Retrospective Database Analysis of Treatment Pathways in US Medicare Patients with Multiple Myeloma Following Sequential Treatment with Lenalidomide and a Proteasome Inhibitor

Natalie Boytsov, Anissa Cyhaniuk, Gary Leung, Feng Wang, Cosmina Hogea, Matthew Lee Smith, Pallavi Mudumby
Journal: Blood
Blood (2021) 138 (Supplement 1): 4963.
https://doi.org/10.1182/blood-2021-152731
Published: 2021
Journal Articles

Treatment Patterns and Outcomes of Patients with Double-Class Refractory or Triple-Class Refractory Multiple Myeloma: A Retrospective US Electronic Health Record Database Study

Feng Wang, Boris Gorsh, Maral DerSarkissian, Prani Paka, Rachel Bhak, Natalie Boytsov, Miriam L. Zichlin, Leah Sansbury, Christopher W. Yee, Shannon Ferrante, Anamika Khanal, Ahmed Noman, Mei Sheng Duh
Journal: Blood
Blood (2021) 138 (Supplement 1): 2705.
https://doi.org/10.1182/blood-2021-152301
Published: 2021
Journal Articles

Current Clinical Practice and Decision-Making in Multiple Myeloma Treatment in the United States of America: A Real-World Survey

Amanda Ribbands, Boris Gorsh, Abigail Bailey, Natalie Boytsov, Emily Luke, Annabel Lambert, Cosmina Hogea
Journal: Blood
Blood (2021) 138 (Supplement 1): 3001.
https://doi.org/10.1182/blood-2021-151281
Published: 2021